The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
2,4-dihydroxybenzophenone binds to AR protein 2,4-dihydroxybenzophenone analog binds to and results in decreased activity of AR protein; 2,4-dihydroxybenzophenone binds to and results in decreased activity of AR protein
2,4-dihydroxybenzophenone results in increased expression of CCND1 mRNA; 2,4-dihydroxybenzophenone results in increased expression of CCND1 protein fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in increased expression of CCND1 mRNA]; fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in increased expression of CCND1 protein]
2,4-dihydroxybenzophenone results in decreased expression of CDH1 protein fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in decreased expression of CDH1 protein]
2,4-dihydroxybenzophenone results in increased expression of CDH2 protein fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in increased expression of CDH2 protein]
2,4-dihydroxybenzophenone analog results in increased expression of ESR1 mRNA 2,4-dihydroxybenzophenone binds to ESR1 protein 2,4-dihydroxybenzophenone binds to and results in increased activity of ESR1 protein; 2,4-dihydroxybenzophenone inhibits the reaction [Estradiol binds to ESR1 protein]
2,4-dihydroxybenzophenone analog results in increased expression of ESR2 mRNA 2,4-dihydroxybenzophenone binds to and results in increased activity of ESR2 protein 2,4-dihydroxybenzophenone binds to ESR2 protein
[FLG gene mutant form affects the susceptibility to 2,4-dihydroxybenzophenone] which results in decreased secretion of FSHB protein; [FLG gene mutant form affects the susceptibility to 2,4-dihydroxybenzophenone] which results in increased secretion of Estradiol; [FLG gene mutant form affects the susceptibility to 2,4-dihydroxybenzophenone] which results in increased secretion of Testosterone
2,4-dihydroxybenzophenone results in increased expression of SNAI1 protein fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in increased expression of SNAI1 protein]
2,4-dihydroxybenzophenone results in increased expression of SNAI2 protein fulvestrant inhibits the reaction [2,4-dihydroxybenzophenone results in increased expression of SNAI2 protein]
2,4-dihydroxybenzophenone results in increased expression of TFF1 mRNA [oxybenzone co-treated with 2,4-dihydroxybenzophenone co-treated with octylmethoxycinnamate co-treated with enzacamene] results in increased expression of TFF1 mRNA; [oxybenzone co-treated with 2,4-dihydroxybenzophenone] results in increased expression of TFF1 mRNA